In prostate cancer, OCT4′s influence extends beyond cancer stem cell maintenance: its overexpression has been associated with increased tumor aggressiveness, enhanced metastatic potential, and resistance to both ADT and chemotherapy [21,22]. The gene discussed is POU5F1; the disease is neoplasm.